When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - Blueprint Medicines's BLU-945 shows encouraging action in preclinical study in lung cancer
Blueprint Medicines Corporation
Blueprint Medicines (BPMC+3.4%) has reported new data from preclinical study of BLU-945, a precision therapy for patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).
More news on: Blueprint Medicines Corporation, Healthcare stocks news,